Influence of transplantation of mesenchymal stem cells and interleukin-10 on experimental allergic encephalomyelitis course
Journal Title: Український неврологічний журнал - Year 2018, Vol 0, Issue 1
Abstract
Objective — to study the influence of the umbilical cordderived mesenchymal stem cells (MSC) and antiinflammatory IL10 injection on experimental allergic encephalomyelitis (ЕАЕ) course in rats. Methods and subjects. 50 white male rats with mean body weight 210 g were enrolled into the study. The recurrent course of the EAE was induced via injection of Freund’s adjuvant into the hind limb on the plantar surface. All animals were distributed into 4 groups depending on the MSC and IL10 treatment scheme. The severity of the EAE was defined via specific severity scale (sum of points). Statistical data was proceeded trough Microsoft Excel. Results. The severity of chronic recurrent EAE during its acme among all groups of animals was the moderate one (1.50 — 2.07 points). In group 1 (control group) we observed the acme of EAE on 22nd day. In group 2 we observed the insignificant worsening of the state of rats (with no statistical reliability) after the transplantation of MSC on the 17th day of EAE. The EAE acme drifted towards day 20, then we observed step-by-step cease of all clinical signs with complete recovery on 32nd day. The intravenous injection of IL10 in group 3 caused mild worsening of the state of rats, where in suboccipital injection of IL10 on the 17th day of EAE caused decrease of EAE severity within couple of days and complete cease of all clinical signs with complete recovery on 31st day. The EAE course before its acme in group 4 (twostage treatment with IL10 and MSC) was similar to group 3. The suboccipital injection of IL10 and MSC on the 17th day of EAE caused dramatic increase of EAE severity during first 2 days. Nevertheless, we observed fastened cease of all clinical signs of EAE in group 4 in comparison to group 2 and 3. Conclusions. The administration of antiinflammatory IL10 and MSC in their different combinations induced the complete cease of all clinical signs of EAE before 32th day of the experiment. The comparison of polynomial regressions proved higher efficacy of IL10 intravenous injections on the 10th day and IL10/MSC on the 17th day of the experiment.
Authors and Affiliations
L. D. Pichkur, S. А. Verbovska, V. V. Vaslovich, S. Т. Akinola, O. G. Deriabina, Ya. O. Pokholenko, O. K. Toporova, N. S. Shuvalova, V. А. Коrdium
Keywords
Related Articles
- EP ID EP292099
- DOI -
- Views 121
- Downloads 0
Clinical case of of lumbar-sacral myelitis HSV2-etiology in a patient with a selective deficiency of natural killers
In this article deals with a typical clinical example of a severe form of acute neuroinfectious lesion of the spinal cord HSV2‑etiology in a patient with minor cellular immunodeficiency, who suffered from often recurrent...
Clinical case of ischemic stroke development associated with nonspecific aortoarteritis (Takayasu disease)
The article describes a clinical case of development of ischemic stroke in the carotid and vertebrobasilar basin associated with nonspecific aortoarteritis (Takayasu disease). The diagnosis is confirmed by magnetic reson...
Structural changes in the brain at the stage of clinically isolated multiple sclerosis
Objective — to estimate the brain atrophy in patients with CIS compared to the control group of healthy individuals. Methods and subjects. Observational, transverse, controlled study of atrophic changes in the brain in...
Rehabilitation measures among the patients with cerebral ischemic hemispheric stroke in early recovery period
Objective — to improve the therapeutic and rehabilitation measures in patients who have undergone cerebral ischemic hemispheric stroke by dividing them into clinic and rehabilitation groups, using modern scales, for a di...
Recommendations on the treatment of patients with active relapsing-remitting multiple sclerosis in Ukraine
On June 1, 2018, the conference of experts, on that examined the pressing questions of diagnostics and treatment of the dissipated sclerosis, took place in Kyiv. On results a conference recommendations are offered in rel...